Search
SOLACI Congress
HomeVeinsVenous Thrombosis

Venous Thrombosis

      View Category

      Antithrombotic Anticoagulants

      ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

      The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will...
      Dr. Omar Tupayachi -
      Learn More
      Peripheral vascular disease

      Contemporary Outcomes of Acute Limb Ischemia Endovascular Revascularization

      Acute limb ischemia (ALI) is a vascular emergency with high mortality rate. It has been defined as...
      Dr. Andrés Rodríguez -
      Learn More
      Peripheral vascular disease

      TCT 2024 | PEERLESS: Mechanical Thrombectomy with FlowTriever vs Catheter-Directed Thrombolysis in Intermediate Risk PTE

      Pulmonary embolism (PE) continues to be the third cause of cardiovascular mortality. The current clinical guidelines recommend...
      Dr. Omar Tupayachi -
      Learn More
      Other

      Catheter-Based Therapy for Pulmonary Embolism: Lower Mortality and Rehospitalization?

      Venous thromboembolism represents one of the main causes of cardiovascular death. Pulmonary embolism (PE) can vary from...
      solaci -
      Learn More
      Highlighted Presentations

      SOLACI-SBHCI 2023 | Acute pulmonary embolysmworkflow: Patient Screening & Endovascular treatment indications – Dr. João Luiz Frighetto

      Read the most outstanding articles from SOLACI-SBHCI 2023 Congress. In this case, check the presentation by Dr. João...
      solaci -
      Learn More
      Peripheral vascular disease

      CLOUT Registry: Thrombectomy in TVP with ClotTriever

      Safety and efficacy of the ClotTriever device in extended deep vein thrombosis.  The endovascular treatment of thromboembolic disease...
      solaci -
      Learn More

      SOLACI is the reference organization for Latin American cardiovascular interventionism.

      Last News

      Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

      Dr. Omar Tupayachi - 0
      Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases of Ellis ruptures type III. In these...

      Is it really necessary to monitor all patients after TAVR?

      Dr. Juan Manuel Pérez - 0
      Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

      Is it really necessary to monitor all patients after TAVR?

      Dr. Juan Manuel Pérez - 0
      Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

      Institutional News

      Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

      solaci - 0
      Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

      Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

      solaci - 0
      Our webinar “SELUTION: Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives”, held on November 19, 2025 via Zoom with...

      25/11 – SOLACI Webinar: Pulmonary Embolism in 2025 – Risk Stratification and Novel Therapeutic Approaches

      solaci - 0
      The Latin American Society of Interventional Cardiology invites you to participate in a new virtual scientific event titled “Pulmonary Embolism (PE) in 2025: Risk...

      Access

      Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy